{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:54:15Z","timestamp":1778702055098,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Molecular Autism"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The etiology of severe childhood speech disorders, including childhood apraxia of speech (CAS), is currently understood as genetically heterogeneous, with over 40 distinct monogenic conditions reported to date. Among them, the p.Thr327Arg variant in\n                      <jats:italic>GNAO1<\/jats:italic>\n                      , encoding the major neuronal G protein G\u03b1o, was identified in one patient diagnosed with CAS and intellectual disability (ID). This presentation is exceptionally rare, as\n                      <jats:italic>GNAO1<\/jats:italic>\n                      mutations are commonly associated with epilepsy, hyperkinetic movement disorders, and global developmental delay, often accompanied by ID.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Here, we describe the clinical course of two patients with\n                      <jats:italic>de novo<\/jats:italic>\n                      heterozygous\n                      <jats:italic>GNAO1<\/jats:italic>\n                      variants\u2014p.Leu39_Gly40insVal and p.Thr327Lys\u2014who exhibit severe speech disorder and ID as prominent symptoms. We also analyzed the biochemical and cellular properties of the mutant G\u03b1o proteins alongside the previously reported p.Thr327Arg variant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Molecular investigation of these three atypical G\u03b1o mutants revealed aberrant GTP binding and hydrolysis, impaired association with RGS19, and a strong neomorphic gain of Ric8A interaction. Yet, all variants show normal plasma membrane localization despite poor G\u03b2\u03b3 association, with p.Leu39_Gly40insVal exhibiting weak coupling to G protein-coupled receptors and p.Thr327Arg\/Lys displaying near-normal coupling. Importantly, all three G\u03b1o variants respond to Zn\n                      <jats:sup>2+<\/jats:sup>\n                      , supporting the potential therapeutic use of zinc supplementation for the patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>\n                      These rare findings are based on a limited number of cases and require confirmation in additional patients to establish firmer genotype\u2013phenotype correlations for\n                      <jats:italic>GNAO1<\/jats:italic>\n                      -related severe speech disorders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our results broaden the clinical and mechanistic spectrum of\n                      <jats:italic>GNAO1<\/jats:italic>\n                      -related disorders, showing that severe speech disorders and ID can occur as defining features even in the absence of seizures or movement disorders. These findings highlight the importance of including\n                      <jats:italic>GNAO1<\/jats:italic>\n                      in genetic testing for children with severe speech disorders.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13229-025-00696-8","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:04:05Z","timestamp":1765523045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Atypical GNAO1 variants in severe childhood speech disorders: clinical, genetic, and molecular insights"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9423-0768","authenticated-orcid":false,"given":"Yonika A.","family":"Larasati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0019-3060","authenticated-orcid":false,"given":"Moritz","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5753-2687","authenticated-orcid":false,"given":"Ainara","family":"Salazar-Villacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-4426","authenticated-orcid":false,"given":"Alexey","family":"Koval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3529-5075","authenticated-orcid":false,"given":"Manju A.","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7991-4432","authenticated-orcid":false,"given":"Anne","family":"Koy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-7405","authenticated-orcid":false,"given":"Angela T.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-5617","authenticated-orcid":false,"given":"Vladimir L.","family":"Katanaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-3780","authenticated-orcid":false,"given":"Gonzalo P.","family":"Solis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"696_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/02699206.2019.1595731","volume":"33","author":"LD Shriberg","year":"2019","unstructured":"Shriberg LD, Kwiatkowski J, Mabie HL. Estimates of the prevalence of motor speech disorders in children with idiopathic speech delay. Clin Linguist Phon. 2019;33:679\u2013706.","journal-title":"Clin Linguist Phon"},{"key":"696_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41380-024-02409-8","volume":"29","author":"AT Morgan","year":"2024","unstructured":"Morgan AT, Amor DJ, St John MD, Scheffer IE, Hildebrand MS. Genetic architecture of childhood speech disorder: a review. Mol Psychiatry. 2024;29:1281\u201392.","journal-title":"Mol Psychiatry"},{"key":"696_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1044\/2021_PERSP-20-00283","volume":"7","author":"J Iuzzini-Seigel","year":"2022","unstructured":"Iuzzini-Seigel J, Delaney AL, Kent RD. Retrospective Case-Control study of communication and motor abilities in 143 children with suspected childhood apraxia of speech: effect of concomitant diagnosis. Perspect ASHA Spec Interest Groups. 2022;7:45\u201355.","journal-title":"Perspect ASHA Spec Interest Groups"},{"key":"696_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ejhg.2012.165","volume":"21","author":"G Raca","year":"2013","unstructured":"Raca G, Baas BS, Kirmani S, Laffin JJ, Jackson CA, Strand EA, et al. Childhood apraxia of speech (CAS) in two patients with 16p11.2 microdeletion syndrome. Eur J Hum Genet. 2013;21:455\u20139.","journal-title":"Eur J Hum Genet"},{"key":"696_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/ejhg.2015.149","volume":"24","author":"E Fedorenko","year":"2016","unstructured":"Fedorenko E, Morgan A, Murray E, Cardinaux A, Mei C, Tager-Flusberg H, et al. A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2. Eur J Hum Genet. 2016;24:302\u20136.","journal-title":"Eur J Hum Genet"},{"key":"696_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s42003-024-06968-y","volume":"7","author":"ER Chan","year":"2024","unstructured":"Chan ER, Benchek P, Miller G, Brustoski K, Schaffer A, Truitt B, et al. Importance of copy number variants in childhood apraxia of speech and other speech sound disorders. Commun Biol. 2024;7:1273.","journal-title":"Commun Biol"},{"key":"696_CR7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41431-018-0102-x","volume":"26","author":"C Mei","year":"2018","unstructured":"Mei C, Fedorenko E, Amor DJ, Boys A, Hoeflin C, Carew P, et al. Deep phenotyping of speech and Language skills in individuals with 16p11.2 deletion. Eur J Hum Genet. 2018;26:676\u201386.","journal-title":"Eur J Hum Genet"},{"key":"696_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13229-025-00642-8","volume":"16","author":"C Ormieres","year":"2025","unstructured":"Ormieres C, Lesieur-Sebellin M, Siquier-Pernet K, Delplancq G, Rio M, Parisot M, et al. Deciphering the genetic basis of developmental Language disorder in children without intellectual disability, autism or apraxia of speech. Mol Autism. 2025;16:10.","journal-title":"Mol Autism"},{"key":"696_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/jpm12020313","volume":"12","author":"AM Chilosi","year":"2022","unstructured":"Chilosi AM, Podda I, Ricca I, Comparini A, Franchi B, Fiori S, et al. Differences and commonalities in children with childhood apraxia of speech and comorbid neurodevelopmental disorders: A multidimensional perspective. J Pers Med. 2022;12:313.","journal-title":"J Pers Med"},{"key":"696_CR10","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41380-018-0020-x","volume":"24","author":"E Eising","year":"2019","unstructured":"Eising E, Carrion-Castillo A, Vino A, Strand EA, Jakielski KJ, Scerri TS, et al. A set of regulatory genes co-expressed in embryonic human brain is implicated in disrupted speech development. Mol Psychiatry. 2019;24:1065\u201378.","journal-title":"Mol Psychiatry"},{"key":"696_CR11","doi-asserted-by":"publisher","first-page":"e2148","DOI":"10.1212\/WNL.0000000000009441","volume":"94","author":"MS Hildebrand","year":"2020","unstructured":"Hildebrand MS, Jackson VE, Scerri TS, Van Reyk O, Coleman M, Braden RO, et al. Severe childhood speech disorder: gene discovery highlights transcriptional dysregulation. Neurology. 2020;94:e2148\u201367.","journal-title":"Neurology"},{"key":"696_CR12","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/s41380-022-01879-y","volume":"28","author":"A Kaspi","year":"2023","unstructured":"Kaspi A, Hildebrand MS, Jackson VE, Braden R, van Reyk O, Howell T, et al. Genetic aetiologies for childhood speech disorder: novel pathways co-expressed during brain development. Mol Psychiatry. 2023;28:1647\u201363.","journal-title":"Mol Psychiatry"},{"key":"696_CR13","doi-asserted-by":"publisher","first-page":"1396240","DOI":"10.3389\/fnins.2024.1396240","volume":"18","author":"D Formicola","year":"2024","unstructured":"Formicola D, Podda I, Dirupo E, Andreucci E, Giglio S, Cipriani P, et al. Expanding the molecular landscape of childhood apraxia of speech: evidence from a single-center experience. Front Neurosci. 2024;18:1396240.","journal-title":"Front Neurosci"},{"key":"696_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00787-024-02452-4","volume":"34","author":"E Granocchio","year":"2025","unstructured":"Granocchio E, Andreoli L, Magazu S, Sarti D, Leonardi E, Murgia A, et al. Expanding the clinical phenotype of SHANK2-related disorders: childhood apraxia of speech in a patient with a novel SHANK2 pathogenic variant. Eur Child Adolesc Psychiatry. 2025;34:815\u20137.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"696_CR15","doi-asserted-by":"publisher","first-page":"6628283","DOI":"10.1155\/2023\/6628283","volume":"2023","author":"M Saez Gonzalez","year":"2023","unstructured":"Saez Gonzalez M, Kloosterhuis K, van de Pol L, Baas F, Mikkers H. Phenotypic diversity in GNAO1 patients: A comprehensive overview of variants and phenotypes. Hum Mutat. 2023;2023:6628283.","journal-title":"Hum Mutat"},{"key":"696_CR16","doi-asserted-by":"publisher","first-page":"105405","DOI":"10.1016\/j.parkreldis.2023.105405","volume":"111","author":"M Novelli","year":"2023","unstructured":"Novelli M, Galosi S, Zorzi G, Martinelli S, Capuano A, Nardecchia F, et al. GNAO1-related movement disorder: an update on phenomenology, clinical course, and response to treatments. Parkinsonism Relat Disord. 2023;111:105405.","journal-title":"Parkinsonism Relat Disord"},{"key":"696_CR17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/jnnp-2022-330261","volume":"94","author":"M Thiel","year":"2023","unstructured":"Thiel M, Bamborschke D, Janzarik WG, Assmann B, Zittel S, Patzer S, et al. Genotype-phenotype correlation and treatment effects in young patients with GNAO1-associated disorders. J Neurol Neurosurg Psychiatry. 2023;94:806\u201315.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"696_CR18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajhg.2013.07.014","volume":"93","author":"K Nakamura","year":"2013","unstructured":"Nakamura K, Kodera H, Akita T, Shiina M, Kato M, Hoshino H, et al. De Novo mutations in GNAO1, encoding a Galphao subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet. 2013;93:496\u2013505.","journal-title":"Am J Hum Genet"},{"key":"696_CR19","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1177\/0883073816666474","volume":"31","author":"LA Menke","year":"2016","unstructured":"Menke LA, Engelen M, Alders M, Odekerken VJ, Baas F, Cobben JM. Recurrent GNAO1 mutations associated with developmental delay and a movement disorder. J Child Neurol. 2016;31:1598\u2013601.","journal-title":"J Child Neurol"},{"key":"696_CR20","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/mds.29074","volume":"37","author":"T Wirth","year":"2022","unstructured":"Wirth T, Garone G, Kurian MA, Piton A, Millan F, Telegrafi A, et al. Highlighting the dystonic phenotype related to GNAO1. Mov Disord. 2022;37:1547\u201354.","journal-title":"Mov Disord"},{"key":"696_CR21","doi-asserted-by":"crossref","unstructured":"Koval A, Larasati YA, Savitsky M, Solis GP, Good JM, Quinodoz M et al. In-depth molecular profiling of an intronic GNAO1 mutant as the basis for personalized high-throughput drug screening. Med. 2023;4:311\u2009\u2013\u200925 e7.","DOI":"10.1016\/j.medj.2023.03.001"},{"key":"696_CR22","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/mds.29881","volume":"39","author":"A Lasa-Aranzasti","year":"2024","unstructured":"Lasa-Aranzasti A, Larasati YA, da Silva Cardoso J, Solis GP, Koval A, Cazurro-Gutierrez A, et al. Clinical and molecular profiling in GNAO1 permits Phenotype-Genotype correlation. Mov Disord. 2024;39:1578\u201391.","journal-title":"Mov Disord"},{"key":"696_CR23","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1007\/s00415-024-12418-w","volume":"271","author":"WG Ludlam","year":"2024","unstructured":"Ludlam WG, Soliani L, Dominguez-Carral J, Cordelli DM, Marchiani V, Gorria-Redondo N, et al. Diverse faces of GNAO1: mild forms in epilepsy and autism. J Neurol. 2024;271:3777\u201381.","journal-title":"J Neurol"},{"key":"696_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/mds.29720","volume":"39","author":"GP Solis","year":"2024","unstructured":"Solis GP, Larasati YA, Thiel M, Koval A, Koy A, Katanaev VL. GNAO1 mutations affecting the N-Terminal alpha-Helix of Galphao lead to parkinsonism. Mov Disord. 2024;39:601\u20136.","journal-title":"Mov Disord"},{"key":"696_CR25","doi-asserted-by":"publisher","first-page":"101522","DOI":"10.1016\/j.gendis.2025.101522","volume":"12","author":"GP Solis","year":"2025","unstructured":"Solis GP, Danti FR, Larasati YA, Graziola F, Croci C, Osanni E, et al. Clinical-molecular profiling of atypical GNAO1 patients: novel pathogenic variants, unusual manifestations, and severe molecular dysfunction. Genes Dis. 2025;12:101522.","journal-title":"Genes Dis"},{"key":"696_CR26","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s44321-025-00274-8","volume":"17","author":"VL Katanaev","year":"2025","unstructured":"Katanaev VL, Solis GP. Dominant Galpha mutations in human disease: unifying mechanisms and treatment strategies. EMBO Mol Med. 2025;17:2168\u201379.","journal-title":"EMBO Mol Med"},{"key":"696_CR27","doi-asserted-by":"publisher","first-page":"13806","DOI":"10.1016\/S0021-9258(18)89817-9","volume":"259","author":"PC Sternweis","year":"1984","unstructured":"Sternweis PC, Robishaw JD. Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J Biol Chem. 1984;259:13806\u201313.","journal-title":"J Biol Chem"},{"key":"696_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nrm2299","volume":"9","author":"WM Oldham","year":"2008","unstructured":"Oldham WM, Hamm HE. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol. 2008;9:60\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"696_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2004.11.014","volume":"120","author":"VL Katanaev","year":"2005","unstructured":"Katanaev VL, Ponzielli R, Semeriva M, Tomlinson A. Trimeric G protein-dependent frizzled signaling in drosophila. Cell. 2005;120:111\u201322.","journal-title":"Cell"},{"key":"696_CR30","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1242\/dev.106773","volume":"141","author":"AM Luchtenborg","year":"2014","unstructured":"Luchtenborg AM, Solis GP, Egger-Adam D, Koval A, Lin C, Blanchard MG, et al. Heterotrimeric go protein links Wnt-Frizzled signaling with ankyrins to regulate the neuronal microtubule cytoskeleton. Development. 2014;141:3399\u2013409.","journal-title":"Development"},{"key":"696_CR31","doi-asserted-by":"publisher","first-page":"113173","DOI":"10.1016\/j.celrep.2023.113173","volume":"42","author":"I Masuho","year":"2023","unstructured":"Masuho I, Kise R, Gainza P, Von Moo E, Li X, Tany R, et al. Rules and mechanisms governing G protein coupling selectivity of GPCRs. Cell Rep. 2023;42:113173.","journal-title":"Cell Rep"},{"key":"696_CR32","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1073\/pnas.0801569105","volume":"105","author":"KC Slep","year":"2008","unstructured":"Slep KC, Kercher MA, Wieland T, Chen CK, Simon MI, Sigler PB. Molecular architecture of Galphao and the structural basis for RGS16-mediated deactivation. Proc Natl Acad Sci U S A. 2008;105:6243\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"696_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.molcel.2014.01.014","volume":"53","author":"C Lin","year":"2014","unstructured":"Lin C, Koval A, Tishchenko S, Gabdulkhakov A, Tin U, Solis GP, et al. Double suppression of the Galpha protein activity by RGS proteins. Mol Cell. 2014;53:663\u201371.","journal-title":"Mol Cell"},{"key":"696_CR34","doi-asserted-by":"publisher","first-page":"108718","DOI":"10.1016\/j.celrep.2021.108718","volume":"34","author":"BS Muntean","year":"2021","unstructured":"Muntean BS, Masuho I, Dao M, Sutton LP, Zucca S, Iwamoto H, et al. Galphao is a major determinant of cAMP signaling in the pathophysiology of movement disorders. Cell Rep. 2021;34:108718.","journal-title":"Cell Rep"},{"key":"696_CR35","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3390\/cells10102749","volume":"10","author":"GP Solis","year":"2021","unstructured":"Solis GP, Kozhanova TV, Koval A, Zhilina SS, Mescheryakova TI, Abramov AA, et al. Pediatric encephalopathy: Clinical, biochemical and cellular insights into the role of Gln52 of GNAO1 and GNAI1 for the dominant disease. Cells. 2021;10:2749.","journal-title":"Cells"},{"key":"696_CR36","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ana.26758","volume":"94","author":"J Dominguez-Carral","year":"2023","unstructured":"Dominguez-Carral J, Ludlam WG, Junyent Segarra M, Fornaguera Marti M, Balsells S, Muchart J, et al. Severity of GNAO1-Related disorder correlates with changes in G-Protein function. Ann Neurol. 2023;94:987\u20131004.","journal-title":"Ann Neurol"},{"key":"696_CR37","doi-asserted-by":"publisher","first-page":"113462","DOI":"10.1016\/j.celrep.2023.113462","volume":"42","author":"KM Knight","year":"2023","unstructured":"Knight KM, Obarow EG, Wei W, Mani S, Esteller MI, Cui M, et al. Molecular annotation of G protein variants in a neurological disorder. Cell Rep. 2023;42:113462.","journal-title":"Cell Rep"},{"key":"696_CR38","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.3390\/cells12202469","volume":"12","author":"YA Larasati","year":"2023","unstructured":"Larasati YA, Solis GP, Koval A, Griffiths ST, Berentsen R, Aukrust I, et al. Clinical cases and the molecular profiling of a novel childhood Encephalopathy-Causing GNAO1 mutation P170R. Cells. 2023;12:2469.","journal-title":"Cells"},{"key":"696_CR39","doi-asserted-by":"publisher","first-page":"e172057","DOI":"10.1172\/JCI172057","volume":"134","author":"GP Solis","year":"2024","unstructured":"Solis GP, Koval A, Valnohova J, Kazemzadeh A, Savitsky M, Katanaev VL. Neomorphic Galphao mutations gain interaction with Ric8 proteins in GNAO1 encephalopathies. J Clin Invest. 2024;134:e172057.","journal-title":"J Clin Invest"},{"key":"696_CR40","doi-asserted-by":"publisher","first-page":"eadu9383","DOI":"10.1126\/scisignal.adu9383","volume":"18","author":"M Savitsky","year":"2025","unstructured":"Savitsky M, Larasati YA, Solis GP, Koval A, Camacho A, Nunez N, et al. Loss of the conserved switch III region in a G protein leads to severe pediatric encephalopathy. Sci Signal. 2025;18:eadu9383.","journal-title":"Sci Signal"},{"key":"696_CR41","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1038\/s41467-024-50964-z","volume":"15","author":"KM Knight","year":"2024","unstructured":"Knight KM, Krumm BE, Kapolka NJ, Ludlam WG, Cui M, Mani S, et al. A neurodevelopmental disorder mutation locks G proteins in the transitory pre-activated state. Nat Commun. 2024;15:6643.","journal-title":"Nat Commun"},{"key":"696_CR42","doi-asserted-by":"publisher","unstructured":"Larasati YA, Rabesahala de Meritens C, Stoeber M, Katanaev VL, Solis GP. Visualizing the dominant GPCR coupling of pathogenic G\u03b1o mutants in GNAO1-Related disorders. bioRxiv. 2025; https:\/\/doi.org\/10.1101\/2025.06.19.660437","DOI":"10.1101\/2025.06.19.660437"},{"key":"696_CR43","doi-asserted-by":"publisher","first-page":"ra79","DOI":"10.1126\/scisignal.2002223","volume":"4","author":"M Gabay","year":"2011","unstructured":"Gabay M, Pinter ME, Wright FA, Chan P, Murphy AJ, Valenzuela DM, et al. Ric-8 proteins are molecular chaperones that direct nascent G protein alpha subunit membrane association. Sci Signal. 2011;4:ra79.","journal-title":"Sci Signal"},{"key":"696_CR44","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.4103\/NRR.NRR-D-24-01550","volume":"21","author":"VL Katanaev","year":"2026","unstructured":"Katanaev VL, Valnohova J. Molecular biomarkers in GNAO1 encephalopathies. Neural Regen Res. 2026;21:1570\u20131.","journal-title":"Neural Regen Res"},{"key":"696_CR45","doi-asserted-by":"crossref","unstructured":"Lasa-Aranzasti A, Solis GP, Katanaev VL, Perez-Duenas B, Response to, Mortimer et al. Clinical and molecular profiling in GNAO1 permits phenotype-genotype correlation. Mov Disord. 2024;39:2125-6.","DOI":"10.1002\/mds.30018"},{"key":"696_CR46","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/mds.30017","volume":"39","author":"M Svec","year":"2024","unstructured":"Svec M, Mantel T, Zech M, Haslinger B. Reply to: clinical and molecular profiling in GNAO1 permits Phenotype-Genotype correlation. Mov Disord. 2024;39:2124\u20135.","journal-title":"Mov Disord"},{"key":"696_CR47","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1002\/mds.29258","volume":"37","author":"M Krenn","year":"2022","unstructured":"Krenn M, Sommer R, Sycha T, Zech M. GNAO1 haploinsufficiency associated with a mild Delayed-Onset dystonia phenotype. Mov Disord. 2022;37:2464\u20136.","journal-title":"Mov Disord"},{"key":"696_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.parkreldis.2022.08.032","volume":"103","author":"A Lasa-Aranzasti","year":"2022","unstructured":"Lasa-Aranzasti A, Cazurro-Gutierrez A, Bescos A, Gonzalez V, Ispierto L, Tardaguila M, et al. 16q12.2q21 deletion: A newly recognized cause of dystonia related to GNAO1 haploinsufficiency. Parkinsonism Relat Disord. 2022;103:112\u20134.","journal-title":"Parkinsonism Relat Disord"},{"key":"696_CR49","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/mds.29585","volume":"38","author":"S Galosi","year":"2023","unstructured":"Galosi S, Novelli M, Di Rocco M, Flex E, Messina E, Pollini L, et al. GNAO1 haploinsufficiency: the milder end of the GNAO1 phenotypic spectrum. Mov Disord. 2023;38:2313\u20134.","journal-title":"Mov Disord"},{"key":"696_CR50","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296\u2013303.","journal-title":"Nucleic Acids Res"},{"key":"696_CR51","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/0092-8674(95)90220-1","volume":"83","author":"MA Wall","year":"1995","unstructured":"Wall MA, Coleman DE, Lee E, Iniguez-Lluhi JA, Posner BA, Gilman AG, et al. The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell. 1995;83:1047\u201358.","journal-title":"Cell"},{"key":"696_CR52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, et al. UCSF chimerax: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70\u201382.","journal-title":"Protein Sci"},{"key":"696_CR53","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.cell.2017.07.015","volume":"170","author":"GP Solis","year":"2017","unstructured":"Solis GP, Bilousov O, Koval A, Luchtenborg AM, Lin C, Katanaev VL. Golgi-Resident Galphao promotes protrusive membrane dynamics. Cell. 2017;170:939\u201355. e24.","journal-title":"Cell"},{"key":"696_CR54","doi-asserted-by":"publisher","first-page":"eabn9350","DOI":"10.1126\/sciadv.abn9350","volume":"8","author":"YA Larasati","year":"2022","unstructured":"Larasati YA, Savitsky M, Koval A, Solis GP, Valnohova J, Katanaev VL. Restoration of the GTPase activity and cellular interactions of Galpha(o) mutants by Zn(2+) in GNAO1 encephalopathy models. Sci Adv. 2022;8:eabn9350.","journal-title":"Sci Adv"},{"key":"696_CR55","doi-asserted-by":"publisher","first-page":"eabf1653","DOI":"10.1126\/scisignal.abf1653","volume":"14","author":"H Schihada","year":"2021","unstructured":"Schihada H, Shekhani R, Schulte G. Quantitative assessment of constitutive G protein-coupled receptor activity with BRET-based G protein biosensors. Sci Signal. 2021;14:eabf1653.","journal-title":"Sci Signal"},{"key":"696_CR56","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/s41467-022-29685-8","volume":"13","author":"GP Solis","year":"2022","unstructured":"Solis GP, Kazemzadeh A, Abrami L, Valnohova J, Alvarez C, van der Goot FG, et al. Local and substrate-specific S-palmitoylation determines subcellular localization of Galphao. Nat Commun. 2022;13:2072.","journal-title":"Nat Commun"},{"key":"696_CR57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/379311a0","volume":"379","author":"DG Lambright","year":"1996","unstructured":"Lambright DG, Sondek J, Bohm A, Skiba NP, Hamm HE, Sigler PB. The 2.0 A crystal structure of a heterotrimeric G protein. Nature. 1996;379:311\u20139.","journal-title":"Nature"},{"key":"696_CR58","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1146\/annurev.biochem.66.1.639","volume":"66","author":"SR Sprang","year":"1997","unstructured":"Sprang SR. G protein mechanisms: insights from structural analysis. Annu Rev Biochem. 1997;66:639\u201378.","journal-title":"Annu Rev Biochem"},{"key":"696_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/abio.2001.5011","volume":"291","author":"DP McEwen","year":"2001","unstructured":"McEwen DP, Gee KR, Kang HC, Neubig RR. Fluorescent BODIPY-GTP analogs: real-time measurement of nucleotide binding to G proteins. Anal Biochem. 2001;291:109\u201317.","journal-title":"Anal Biochem"},{"key":"696_CR60","doi-asserted-by":"publisher","first-page":"7712","DOI":"10.1074\/jbc.M413810200","volume":"280","author":"EE Jameson","year":"2005","unstructured":"Jameson EE, Roof RA, Whorton MR, Mosberg HI, Sunahara RK, Neubig RR, et al. Real-time detection of basal and stimulated G protein GTPase activity using fluorescent GTP analogues. J Biol Chem. 2005;280:7712\u20139.","journal-title":"J Biol Chem"},{"key":"696_CR61","doi-asserted-by":"publisher","first-page":"eabn9350","DOI":"10.1126\/sciadv.abn9350","volume":"8","author":"Y Larasati","year":"2022","unstructured":"Larasati Y, Savitsky M, Koval A, Solis GP, Valnohova J, Katanaev VL. Restoration of the GTPase activity and cellular interactions of G\u03b1o mutants by Zn2\u2009+\u2009in GNAO1 encephalopathy models. Sci Adv. 2022;8:eabn9350.","journal-title":"Sci Adv"},{"key":"696_CR62","doi-asserted-by":"publisher","first-page":"100495","DOI":"10.1016\/j.medj.2024.07.023","volume":"6","author":"YA Larasati","year":"2025","unstructured":"Larasati YA, Thiel M, Koval A, Silachev DN, Koy A, Katanaev VL. Zinc for GNAO1 encephalopathy: preclinical profiling and a clinical case. Med. 2025;6:100495.","journal-title":"Med"},{"key":"696_CR63","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/WNL.0000000000001228","volume":"84","author":"SJ Turner","year":"2015","unstructured":"Turner SJ, Mayes AK, Verhoeven A, Mandelstam SA, Morgan AT, Scheffer IE. GRIN2A: an aptly named gene for speech dysfunction. Neurology. 2015;84:586\u201393.","journal-title":"Neurology"},{"key":"696_CR64","doi-asserted-by":"publisher","first-page":"e200181","DOI":"10.1212\/NXG.0000000000200181","volume":"10","author":"MS Hildebrand","year":"2024","unstructured":"Hildebrand MS, Braden RO, Lauretta ML, Kaspi A, Leventer RJ, Anderson M, et al. Inherited PURA pathogenic variant associated with a mild neurodevelopmental disorder. Neurol Genet. 2024;10:e200181.","journal-title":"Neurol Genet"},{"key":"696_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13023-016-0416-0","volume":"11","author":"A Marce-Grau","year":"2016","unstructured":"Marce-Grau A, Dalton J, Lopez-Pison J, Garcia-Jimenez MC, Monge-Galindo L, Cuenca-Leon E, et al. GNAO1 encephalopathy: further delineation of a severe neurodevelopmental syndrome affecting females. Orphanet J Rare Dis. 2016;11:38.","journal-title":"Orphanet J Rare Dis"},{"key":"696_CR66","doi-asserted-by":"publisher","first-page":"e52803","DOI":"10.15252\/embr.202152803","volume":"22","author":"J den Hoed","year":"2021","unstructured":"den Hoed J, Devaraju K, Fisher SE. Molecular networks of the FOXP2 transcription factor in the brain. EMBO Rep. 2021;22:e52803.","journal-title":"EMBO Rep"},{"key":"696_CR67","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1073\/pnas.95.6.3269","volume":"95","author":"M Jiang","year":"1998","unstructured":"Jiang M, Gold MS, Boulay G, Spicher K, Peyton M, Brabet P, et al. Multiple neurological abnormalities in mice deficient in the G protein go. Proc Natl Acad Sci U S A. 1998;95:3269\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"696_CR68","doi-asserted-by":"publisher","first-page":"10974","DOI":"10.1073\/pnas.1613026113","volume":"113","author":"JM Choi","year":"2016","unstructured":"Choi JM, Kim SS, Choi CI, Cha HL, Oh HH, Ghil S, et al. Development of the main olfactory system and main olfactory epithelium-dependent male mating behavior are altered in Go-deficient mice. Proc Natl Acad Sci U S A. 2016;113:10974\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"696_CR69","doi-asserted-by":"publisher","first-page":"16601","DOI":"10.1096\/fj.202001113R","volume":"34","author":"S Akamine","year":"2020","unstructured":"Akamine S, Okuzono S, Yamamoto H, Setoyama D, Sagata N, Ohgidani M, et al. GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons. FASEB J. 2020;34:16601\u201321.","journal-title":"FASEB J"},{"key":"696_CR70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40478-022-01312-z","volume":"10","author":"D Silachev","year":"2022","unstructured":"Silachev D, Koval A, Savitsky M, Padmasola G, Quairiaux C, Thorel F, et al. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation. Acta Neuropathol Commun. 2022;10:9.","journal-title":"Acta Neuropathol Commun"},{"key":"696_CR71","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1086\/522237","volume":"81","author":"E Spiteri","year":"2007","unstructured":"Spiteri E, Konopka G, Coppola G, Bomar J, Oldham M, Ou J, et al. Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am J Hum Genet. 2007;81:1144\u201357.","journal-title":"Am J Hum Genet"},{"key":"696_CR72","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1086\/522238","volume":"81","author":"SC Vernes","year":"2007","unstructured":"Vernes SC, Spiteri E, Nicod J, Groszer M, Taylor JM, Davies KE, et al. High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and Language disorders. Am J Hum Genet. 2007;81:1232\u201350.","journal-title":"Am J Hum Genet"},{"key":"696_CR73","doi-asserted-by":"publisher","first-page":"e1002145","DOI":"10.1371\/journal.pgen.1002145","volume":"7","author":"SC Vernes","year":"2011","unstructured":"Vernes SC, Oliver PL, Spiteri E, Lockstone HE, Puliyadi R, Taylor JM, et al. Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. PLoS Genet. 2011;7:e1002145.","journal-title":"PLoS Genet"},{"key":"696_CR74","doi-asserted-by":"publisher","first-page":"e26656","DOI":"10.1016\/j.heliyon.2024.e26656","volume":"10","author":"MC Benedetti","year":"2024","unstructured":"Benedetti MC, D\u2019Andrea T, Colantoni A, Silachev D, de Turris V, Boussadia Z, et al. Cortical neurons obtained from patient-derived iPSCs with GNAO1 p.G203R variant show altered differentiation and functional properties. Heliyon. 2024;10:e26656.","journal-title":"Heliyon"}],"container-title":["Molecular Autism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-025-00696-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13229-025-00696-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-025-00696-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:02:37Z","timestamp":1767862957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13229-025-00696-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["696"],"URL":"https:\/\/doi.org\/10.1186\/s13229-025-00696-8","relation":{},"ISSN":["2040-2392"],"issn-type":[{"value":"2040-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics declarations"}},{"value":"Ethical standards and guidelines of the UCL Institute of Child Health and Great Ormond Street Hospital, and the University Hospital of Cologne were followed during the whole process. Written informed consent was provided by participants\u2019 parents or caregivers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients\u2019 parents or caregivers for publication of anonymized patient-related information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}